Currently covering 11,000 square meters, the site is expected to expand to 21,000 square meters upon completion. The $35 million investment will also bring a significant boost to the company’s workforce, adding 500 new employees. This includes specialists for the company’s first research and development (R&D) laboratory in Costa Rica.

“We are dedicated to investing in the space and resources necessary to meet customer demands and drive double-digit growth annually,” said Heiko Specht, President of Heraeus Medevio. “This expansion will allow us to help our customers bring medical devices to market faster while advancing our goal of improving 100 million lives each year.”

Phase III will enhance the company’s manufacturing capabilities, featuring the addition of an electrophysiology assembly line for the production of specialized catheters with electronic components. These advanced devices are designed to help treat arrhythmia (irregular heartbeats) through a procedure called ablation.

Heraeus Medevio first established operations in Costa Rica in June 2017. As of January 2025, the company employs 650 people and expects to hire an additional 500 staff following the completion of Phase III. Job openings are available across various departments, including R&D, engineering, and production. Interested candidates can apply via the company’s career website.

Heraeus Medevio is one of several international companies increasing their investment in Costa Rica. Last week, Harland Medical Systems, based in Minnesota, also announced the launch of operations in the country, specializing in coatings for the medical device industry.

Despite this influx of foreign investment and job creation, Costa Rica’s unemployment rate remains at 6.9%, according to the National Employment Survey. Data from October to December 2024 show that over 165,000 people are unemployed, with men making up 57% of the total or approximately 95,000 individuals.